Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2020 08:59 ET | Source: Syneos Health, Inc.

Syneos Health Completes Acquisition of Synteract

MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
December 07, 2020 17:18 ET | Source: Syneos Health, Inc.

Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event

Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...
December 03, 2020 08:49 ET | Source: Syneos Health, Inc.

Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research

BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
December 02, 2020 08:30 ET | Source: Syneos Health, Inc.

Syneos Health Announces Pricing of Secondary Offering of Common Stock

MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
December 01, 2020 16:21 ET | Source: Syneos Health, Inc.

Syneos Health Announces Secondary Offering of Common Stock

MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
November 24, 2020 18:07 ET | Source: Syneos Health, Inc.

Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029

MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
November 18, 2020 18:52 ET | Source: Syneos Health, Inc.

Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029

MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
November 18, 2020 07:22 ET | Source: Syneos Health, Inc.

Syneos Health Announces Senior Notes Offering

MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
November 17, 2020 08:40 ET | Source: Syneos Health, Inc.

Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer

MORRISVILLE, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A....
November 16, 2020 08:43 ET | Source: Syneos Health, Inc.

Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020

MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...